Fischer Laurent 4
4 · Adverum Biotechnologies, Inc. · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Fischer Laurent
DirectorCEO, PRESIDENT AND DIRECTOR
Transactions
- Purchase
Common Stock
2025-12-05$4.24/sh+11,085$47,000→ 83,899 total - Purchase
Common Stock
2025-12-08$4.31/sh+117,614$506,916→ 201,513 total
Footnotes (3)
- [F1]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.21 to $4.25. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 600 shares purchased on May 21, 20125 and 600 shares purchased on November 20, 2025, pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.
- [F3]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.25 to $4.32. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.